Insight Into New Brown Adipose Tissue Activators.

Sponsor

Medical University of Bialystok (Other)

Overall Status

Completed

CT.gov ID

NCT04787952

Collaborator

(none)

Enrollment

16.8

Actual Duration (Months)

Study Details

Study Description

Brief Summary

The general purpose of the study was to provide new information about the role of macronutrients intake, metabolomics, proteomics and microRNA on BAT activation.

The invesigator evaluated BAT activity and whole body energy consumption under cold stimulation in two gruops of healthy males aged 21-43 years old with normal BMI ( 19-25kg/m2) and in overweight/obese subjects.

Condition or Disease	Intervention/Treatment	Phase
Adiposity Metabolic Complication Metabolic Disturbance Healthy Obesity Diet Habit Nutritional and Metabolic Diseases	Other: cold expossure

Detailed Description

In detail, the main objectives of this study was to measure the influence of biological molecules of such fields: genomics, transcriptomics metabolomics and protemics and its relationship on BAT activation. The investigator also evaluated the role of diet, macronutirnets intake and polyunsaturated fatty acids on BAT activity.

Study design:

SCREENING VISIT:

obtaining written informed consent from all subjects
physical examination
body composition analysis ( DXA + bioindepedance method inbody 720)

Laboratory analyses:

Oral glucose tolerance test ( OGGT 75g)
Morphology
CRP
Creatinine
Urine analysis
Lipids profile
TSH
ALT,AST

Dietary analysis All subjects fulfilled a 3-day food diary. Subjects were asked to compare the portion sizes with the colour photographs of each portion size, and to weigh food, if possible. The daily total energy, macronutrients, monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), omega-3, and omega-6 fatty acids intake were analysed.

STUDY VISITS: Patients who met the inclusion criteria and passed the screening stage were invited for the first visit when PET / MRI after 2h of cold exposure was performed.

Subjects were studied in the morning, from approximately 8 a.m. to 12 a.m., after an overnight fast beginning at 10 p.m. the night before. At the beginning of the day on which the PET study was performed, a catheter was inserted in the subject's antecubital vein for a bolus injection of 18F-FDG. Another catheter was inserted in the antecubital vein of the contralateral arm and was used to obtain samples of venous blood.

The subjects rested in a supine position under thermoneutral conditions (22°C) for 1 hour and then participants were exposed to cooling for 2 hours. The water perfused blankets were used in the applied protocol of cooling. Blood samples were taken before as well as in 60th and 120th min of cooling. Subjects were cooled until shivering and then temperature is set slightly (1-2°C) above the temperature that causes the onset of shivering. Shivering were confirmed by visual inspection and by asking the subject each 15 min. After 2 hour the tracer 18F-FDG (4 MBq/kg ) was administered intravenously, and scanning was performed after the injection of tracer.

Skin temperatures were measured continually by means of electrode attached to skin below armpit.

During the cold exposure, whole body resting energy expenditure (REE) was assessed by a computed open-circuit indirect calorimetry method- based on the consumption of O2 and the production of CO2. The 30 min long measurements of resting oxygen uptake and resting carbon dioxide production were performed by a ventilated canopy Vmax Encore 29n System (Viasys HealthCare, Yorba Linda, CA, USA) at the baseline ( -30 min to 0 min) and every 30 min until 120 min of cold exposure.

During PET-MRI scanning blood samples were taken in 5', 10' 20' 30' 40' to check the activity of 18-FDG. After PET/MRI patient's urine was collected and analyzed for activity of tracer. Blood samples were taken for analysis before the cold exposure, at 60 min and 120 min during the cold exposure to evaluate:

Glucose, IL-6, Insulin, Free Fatty Acids (FFA), TSH, fT4,fT3, Irisin, Atrial natriuretic peptide (ANP), Brain natriuretic peptide (BNP), plasma nonesterified fatty acid (NEFA), DNA, Peripheral Blood Mononuclear Cell (PBMC) for microRNA isolation, metabolomics and proteomics analysis.

SUMMARY:

The goal of our study is to search for new mechanisms that stimulate activation of BAT. It is likely that individuals with different content and activity of the brown adipose will have different set of serum markers after exposure to cold. This will allow the identification of new biomarkers and to understand the molecular mechanisms responsible for the activation of the brown adipose tissue. The outcomes will enable to find new potential therapeutic and diagnostic applications given to the current obesity pandemic.

Study Design

Study Type:

Observational

Actual Enrollment :

40 participants

Observational Model:

Other

Time Perspective:

Prospective

Official Title:

Searching for the New Mechanisms That Activate Brow Fat Tissue

Actual Study Start Date :

Oct 1, 2016

Actual Primary Completion Date :

Feb 24, 2018

Actual Study Completion Date :

Feb 24, 2018

Arms and Interventions

Arm	Intervention/Treatment
Group 1= healthy subjects Inclusion criteria to the group 1 (healthy males) N=20: BMI <25 kg/m2; RR<140/90mmHg; age 21-43 years fasting glycemia <100mg/dl; 2h-OGTT <140mg/dl; no chronic disease	Other: cold expossure subjects were exposed for the cold, to activate and diagnose potential brown tissue activity
Group 2 = overweight/obese subjects Inclusion criteria to the group 2 ( overweight/obese males ) N=20: Blood pressure < 140/90 mmHg (well controlled by inh ACE; no beta-blockers) No chronic disease BMI > 25 <35kg/m² fasting glycemia <100mg/dl; 2h-OGTT <140mg/dl; age 21-43 years	Other: cold expossure subjects were exposed for the cold, to activate and diagnose potential brown tissue activity

Arm

Intervention/Treatment

Group 1= healthy subjects

Inclusion criteria to the group 1 (healthy males) N=20: BMI <25 kg/m2; RR<140/90mmHg; age 21-43 years fasting glycemia <100mg/dl; 2h-OGTT <140mg/dl; no chronic disease

Other: cold expossure

subjects were exposed for the cold, to activate and diagnose potential brown tissue activity

Group 2 = overweight/obese subjects

Inclusion criteria to the group 2 ( overweight/obese males ) N=20: Blood pressure < 140/90 mmHg (well controlled by inh ACE; no beta-blockers) No chronic disease BMI > 25 <35kg/m² fasting glycemia <100mg/dl; 2h-OGTT <140mg/dl; age 21-43 years

Other: cold expossure

subjects were exposed for the cold, to activate and diagnose potential brown tissue activity

Outcome Measures

Primary Outcome Measures

The potential associations between BAT activity and dietary intake [2016-2018]
The relationship between BAT activity and dietary intake will be analyzed
The potential associations between BAT activity and metabolite profile [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The potential molecules will be identified by metabolomics approach and will be analyzed dependently on the brown tissue activity level
The potential associations between BAT activity and proteins profile [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The potential molecules will be identified by proteomics approach and will be analyzed dependently on the brown tissue activity level
The potential associations between BAT activity and transcriptome profile [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The potential molecules will be identified by transriptomics approach and will be analyzed dependently on the brown tissue activity level

Secondary Outcome Measures

The potential associations between BAT activity and Interleukin-6 concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The IL-6 concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and energy expenditure [at the baseline ( -30 min to 0 min) and every 30 min until 120 min of cold exposure]
The energy expenditure was measured before and during the cold exposure, and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and substrates utilization [at the baseline ( -30 min to 0 min) and every 30 min until 120 min of cold exposure.]
The substrates utilization was measured before and during the cold exposure, and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and glucose concentrations [he baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The glucose concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and insulin concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The insulin concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and FFA ( free fatty acids) concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The FFA concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and irisin concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The irisin concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and atrial natiuretic peptide concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The atrial natriuretic peptide concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and brain natiuretic peptide concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The brain natriuretic peptide concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and plasma nonesterified fatty acid concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The plasma nonesterified fatty acid concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and TSH concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The TSH concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and fT3 concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposure]
The fT3 concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity
The potential associations between BAT activity and fT4 concentrations [the baseline (before cold exposure) and after 1st hour and 2nd hour of cold exposu]
The fT4 concentration was measured before and during cold exposure and analyzed dependently on brown adipose tissue activity

Eligibility Criteria

Criteria

Ages Eligible for Study:

20 Years to 43 Years

Sexes Eligible for Study:

Male

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Inclusion criteria to the group 1 (healthy males) N=20:

BMI <25 kg/m2;
RR<140/90mmHg;
age 20-30/40 years
fasting glycemia <100mg/dl; 2h-OGTT <140mg/dl;
no chronic disease

Inclusion criteria to the group 2 ( overweight/obese males) N=20:

Blood pressure < 140/90 mmHg (well controlled by inh ACE; no beta-blockers)
No chronic disease
BMI > 25 <35kg/m²
fasting glycemia <100mg/dl; 2h-OGTT <140mg/dl;

Exclusion Criteria:

Any drug use: beta-blokers, statins, glucocorticoids drugs, hypertension drugs;
hypertension;
cancer;
hormonal disorders;
Inflammation process
Smoking
Claustrophobia

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Medical University of Bialystok

Investigators

Principal Investigator: Katarzyna Maliszewska, PhD, Medical University of Bialystok, Poland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Medical University of Bialystok

ClinicalTrials.gov Identifier:

NCT04787952

Other Study ID Numbers:

UMB24/02/2021

First Posted:

Mar 9, 2021

Last Update Posted:

Mar 10, 2021

Last Verified:

Mar 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Medical University of Bialystok

brown adipose tissue, obesity, diabetes type 2

Additional relevant MeSH terms:

Metabolic Diseases

Study Results

No Results Posted as of Mar 10, 2021